Interpretation of long-term overall survival from the PRODIGE 23 study. Letter to the Editor regarding “Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial”, by T. Conroy et al.